Seattle
University of Washington
Dr. Neumann is an entrepreneur in the MPS space. His career started at the University of Halle, Germany, where he developed some of the first organoid models. At the University of Washington in Seattle, he developed a technology for generating perfusable living microtissues in microfluidic devices. In 2007 he founded Nortis, one of the first organ-on-chip companies which he led as CEO and CSO until recently. Dr. Neumann has been playing a prominent role in promoting the emergence and growth of the MPS field through scientific collaborations, involvement in MPS-focused consortia, and interactions with the NIH, FDA, NASA, and other organizations.